Cargando…
Catheter ablation in patients with persistent atrial fibrillation
Catheter ablation is increasingly offered to patients who suffer from symptoms due to atrial fibrillation (AF), based on a growing body of evidence illustrating its efficacy compared with antiarrhythmic drug therapy. Approximately one-third of AF ablation procedures are currently performed in patien...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353871/ https://www.ncbi.nlm.nih.gov/pubmed/27389907 http://dx.doi.org/10.1093/eurheartj/ehw260 |
_version_ | 1782515218699517952 |
---|---|
author | Kirchhof, Paulus Calkins, Hugh |
author_facet | Kirchhof, Paulus Calkins, Hugh |
author_sort | Kirchhof, Paulus |
collection | PubMed |
description | Catheter ablation is increasingly offered to patients who suffer from symptoms due to atrial fibrillation (AF), based on a growing body of evidence illustrating its efficacy compared with antiarrhythmic drug therapy. Approximately one-third of AF ablation procedures are currently performed in patients with persistent or long-standing persistent AF. Here, we review the available information to guide catheter ablation in these more chronic forms of AF. We identify the following principles: Our clinical ability to discriminate paroxysmal and persistent AF is limited. Pulmonary vein isolation is a reasonable and effective first approach for catheter ablation of persistent AF. Other ablation strategies are being developed and need to be properly evaluated in controlled, multicentre trials. Treatment of concomitant conditions promoting recurrent AF by life style interventions and medical therapy should be a routine adjunct to catheter ablation of persistent AF. Early rhythm control therapy has a biological rationale and trials evaluating its value are underway. There is a clear need to generate more evidence for the best approach to ablation of persistent AF beyond pulmonary vein isolation in the form of adequately powered controlled multi-centre trials. |
format | Online Article Text |
id | pubmed-5353871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-53538712017-03-23 Catheter ablation in patients with persistent atrial fibrillation Kirchhof, Paulus Calkins, Hugh Eur Heart J Reviews Catheter ablation is increasingly offered to patients who suffer from symptoms due to atrial fibrillation (AF), based on a growing body of evidence illustrating its efficacy compared with antiarrhythmic drug therapy. Approximately one-third of AF ablation procedures are currently performed in patients with persistent or long-standing persistent AF. Here, we review the available information to guide catheter ablation in these more chronic forms of AF. We identify the following principles: Our clinical ability to discriminate paroxysmal and persistent AF is limited. Pulmonary vein isolation is a reasonable and effective first approach for catheter ablation of persistent AF. Other ablation strategies are being developed and need to be properly evaluated in controlled, multicentre trials. Treatment of concomitant conditions promoting recurrent AF by life style interventions and medical therapy should be a routine adjunct to catheter ablation of persistent AF. Early rhythm control therapy has a biological rationale and trials evaluating its value are underway. There is a clear need to generate more evidence for the best approach to ablation of persistent AF beyond pulmonary vein isolation in the form of adequately powered controlled multi-centre trials. Oxford University Press 2017-01-01 2016-07-07 /pmc/articles/PMC5353871/ /pubmed/27389907 http://dx.doi.org/10.1093/eurheartj/ehw260 Text en © The Author 2016. Published by Oxford University Press on behalf of the European Society of Cardiology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Kirchhof, Paulus Calkins, Hugh Catheter ablation in patients with persistent atrial fibrillation |
title | Catheter ablation in patients with persistent atrial fibrillation |
title_full | Catheter ablation in patients with persistent atrial fibrillation |
title_fullStr | Catheter ablation in patients with persistent atrial fibrillation |
title_full_unstemmed | Catheter ablation in patients with persistent atrial fibrillation |
title_short | Catheter ablation in patients with persistent atrial fibrillation |
title_sort | catheter ablation in patients with persistent atrial fibrillation |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353871/ https://www.ncbi.nlm.nih.gov/pubmed/27389907 http://dx.doi.org/10.1093/eurheartj/ehw260 |
work_keys_str_mv | AT kirchhofpaulus catheterablationinpatientswithpersistentatrialfibrillation AT calkinshugh catheterablationinpatientswithpersistentatrialfibrillation |